ARTICLE | Clinical News
Lestaurtinib: Preliminary Phase II data
June 22, 2009 7:00 AM UTC
Top-line data from an open-label, international, pivotal Phase II trial in 224 patients with relapsed AML expressing FLT3-activating mutations showed that lestaurtinib plus chemotherapy missed the pri...